Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Schizophr Res. 2014 Aug 10;161(1):113–118. doi: 10.1016/j.schres.2014.07.031

Table 1.

Clinical and experimental parameters

Controls Schizophrenia
n 25 29
female 5 4
male 20 25
CPZ (mg/day) 451 ± 273
duration of illness (months) 15 ± 10.5
IQ 98.92 10.12 101.1 14.7 p=0.64
PSES 2.79 1.38 2.81 0.94 p=0.96
age (years) 43.68 ± 7.62 46.59 ± 9.504 p=0.30
education (years) 14.35 ± 1.843 13.75 ± 2.51 p=0.16
motion (mm) 0.777 ± 0.13 0.786 ± 0.184 p=0.84

CPZ = chlorpromazine equivalent daily dosage; PSES = Parental social economic status